Lactulose Ratiopharm

Lactulose, the active ingredient in Lactulose Ratiopharm, is an osmotic laxative presented as an oral solution for oral use. It is employed to relieve constipation and to manage hepatic encephalopathy by reducing intestinal ammonia absorption.

GNH USA supplies Lactulose Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lactulose is used in gastrointestinal and hepatic conditions where osmotic activity is required. - Constipation: softens stool and promotes regular bowel movements. - Hepatic encephalopathy: lowers blood ammonia levels to improve neurological symptoms. - Prevention of hepatic encephalopathy recurrence: maintains low ammonia concentrations to reduce future episodes.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping or discomfort. - Flatulence or gas buildup. - Diarrhea or loose stools. - Nausea or mild vomiting. - Bloating or a feeling of fullness.

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia). - Marked dehydration requiring medical attention. - Allergic reactions such as rash, itching, or swelling. - Severe abdominal pain persisting beyond initial treatment. - Acute hepatic decompensation in vulnerable patients.

When prescribing Lactulose, clinicians should consider several safety aspects. - Renal function assessment: adjust use in patients with impaired kidney function. - Electrolyte monitoring: watch for disturbances, especially with high doses. - Diabetes caution: monitor blood glucose as lactulose can affect sugar levels. - Concomitant laxative use: avoid excessive bowel‑cleansing effects. - Hepatic impairment: dose may need modification in severe liver disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Concurrent use with strong antidiarrheal agents (e.g., loperamide) may reduce Lactulose effectiveness. - Co‑administration with other osmotic laxatives can increase risk of severe electrolyte loss.

Moderate Interactions (Monitor Closely): - Oral hypoglycemic drugs: Lactulose may affect glucose control; monitor blood sugar. - Diuretics: combined effect may exacerbate electrolyte disturbances. - Mineral or vitamin supplements: absorption may be reduced; consider timing of doses.